ストックスクリーナーアプリを入手
43.90
0.50%
0.22
アフターアワーズ：
43.90
Corcept Therapeutics Inc (CORT) 最新ニュース
CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics ... - Caledonian Record
INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class ActionHagens Berman - Barchart.com
Deadline Alert: Corcept Therapeutics Incorporated (CORT) - GlobeNewswire
Corcept Therapeutics (CORT) climbs 19.7% as Lifyorli gets FDA OK - MSN
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept - GlobeNewswire
CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - ACCESS Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Pomerantz LLP Shares Class Action Details With Shareholders in Corcept Therapeutics Incorporated – CORT - ACCESS Newswire
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure - The Malaysian Reserve
Press releases provided by CNW - Techaeris
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - PR Newswire
Corcept Leaders Sued Over Drug-Approval Remarks, Stock Sales - Bloomberg Law News
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
Corcept Therapeutics Incorporated Sued for Securities Law - GlobeNewswire
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
Corcept's Lifyorli Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer - National Today
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
How The Corcept Therapeutics (CORT) Investment Story Is Shifting After Legal And Regulatory Updates - Yahoo Finance
Corcept’s Lifyorli shows 35% reduction in death risk for ovarian cancer - Investing.com Australia
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - NewMediaWire
FinancialContentDEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - FinancialContent
Corcept Therapeutics (CORT) Unveils Promising Survival Data from ROSELLA Trial - GuruFocus
Corcept Presents Complete Data from Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous Publication in The Lancet: Lifyorli™ (Relacorilant) Plus Nab-Paclitaxel Improves Overall Survival in Patients with Platinum-Resistant Ovarian Cancer - Business Wire
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds - Yahoo Finance
INVESTOR DEADLINE: Corcept Therapeutics (CORT) Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire
CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit ... - Bluefield Daily Telegraph
CORT Shareholder Alert: Corcept Therapeutics Incorporated - GlobeNewswire
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Contact Kaplan Fox Before April 21, 2026 - FinancialContent
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Corcept Therapeutics (CORT) - The Globe and Mail
CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
CORT Investors Have Opportunity to Lead Corcept - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire
Corcept therapeutics officer Guyer sells $819k in shares By Investing.com - Investing.com UK
Corcept (NASDAQ: CORT) CDO sells 20,000 shares after option exercise - Stock Titan
Corcept (CORT) director Wilson reports 5,000-share stock gift via trust - Stock Titan
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Inve - The National Law Review
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics - GlobeNewswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026 - FinancialContent
Corcept Therapeutics Inc (NASDAQ:CORT): An Affordable Growth Stock Built on a Strong Foundation - ChartMill
Corcept Therapeutics Incorporated Securities Fraud Class - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill
Corcept (CORT) Class Action Alleges Misstatements on FDA Data ConcernsHagens Berman - ChartMill
Insider sells 20,000 CORT shares after option exercise (CORT) - Stock Titan
CORT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Inc - GuruFocus
Future of Pituitary Cancer Market (2026-2033) | Precision - openPR.com
CORT DEADLINE NOTICE: Corcept Therapeutics Incorporated Investors Encouraged to Contact Kirby McInerney LLP By April 21, 2026 - ACCESS Newswire
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost M - GuruFocus
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):